本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evogene Ltd.

0.8208
+0.00100.12%
成交量:8,993.00
成交额:7,281.51
市值:812.08万
市盈率:-0.76
高:0.8209
开:0.7906
低:0.7906
收:0.8198
52周最高:2.42
52周最低:0.7200
股本:989.38万
流通股本:980.58万
量比:0.28
换手率:0.09%
股息:- -
股息率:- -
每股收益(TTM):-1.0800
每股收益(LYR):-1.0776
净资产收益率:-100.69%
总资产收益率:-28.77%
市净率:-99.03
市盈率(LYR):-0.76

数据加载中...

2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/21

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/11/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]